Lung transplantation in children with idiopathic pulmonary arterial hypertension

Pediatric Pulmonology

Volumn 45, Issue 3, 2010, Pages 263-269

  Lammers, Astrid E ^a   Burch, Michael ^a   Benden, Christian ^a   Elliott, Martin J ^a   Rees, Philip ^a   Haworth, Sheila G ^a   Aurora, Paul ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; VASODILATOR AGENT;

ARTICLE; CHILD; CLINICAL ARTICLE; EXERCISE; FEMALE; HEART LUNG TRANSPLANTATION; HEART RIGHT VENTRICLE FUNCTION; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC DISEASE; LUNG ARTERY PRESSURE; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; MALE; OXYGEN TENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULAR RESISTANCE INDEX; SPIROMETRY; TREATMENT OUTCOME; WALKING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; INFANT; LUNG TRANSPLANTATION; MALE; PATIENT SELECTION; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 77449095243     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21168     Document Type: Article

References (31)

1. Yung D, Widlitz AC, Rosenzweig EB, Kerstein D, Maislin G, Barst R. Outcomes in children with idiopathic pulmonary arterial hypertension. Circulation 2004;110:660-665.
2. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourkge RC, Brundage BH, et al. A comparison of continuous intravenous epoprostenol (Prostacyclin) with conventional therapy for primary pulmonary hypertension. N Eng J Med 1996;334:230-296.
3. McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension. The impact of epoprostenol therapy. Circulation 2002;106:1477-1482.
4. Simpson CM, Penny DJ, Cochrane AD, Davis AM, Rose ML, Wilson SE, Weintraub RG. Preliminary experience with bosentan as initial therapy in childhood idiopathic pulmonary arterial hypertension. J Heart Lung Transplant 2006;25:469-473.
5. D'Alonzo G, Bart R, Ayres S, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991;115:343-349.
6. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987;107:216-223.
7. Mallory GB, Spray TL. Paediatric lung transplantation. Eur Respir J 2004;24:839-845.
8. Aurora P, Boucek MM, Christie J, et al. Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric lung and heart/lung transplantation report - 2007. J Heart Lung Transplant 2007;26:1223-1228.
9. Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006;25:745-755.
10. Radley-Smith R, Aurora P. Transplantation as a treatment for end-stage pulmonary hypertension in childhood. Paediatr Respir Rev 2006;7:117-122.
11. Benden C, Aurora P. Paediatric aspects of lung transplantation. Eur Respir Mon 2009;45:251-265.
12. Benden C, Harpur-Sinclair O, Ranasinghe AS, Hartley JC, Elliott MJ, Aurora P. Surveillance bronchoscopy in children during the first year after lung transplantation: is it worth it? Thorax 2007; 62:57-61.
13. Maiya S, Hislop AA, Flynn Y, Haworth SG. Response to bosentan in children with pulmonary hypertension. Heart 2006;92:664-670.
14. Lammers AE, Hislop AA, Flynn Y, Haworth SG. Epoprostenol treatment in children with severe pulmonary hypertension. Heart 2007;93:739-743.
15. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000; 8:1-27. (http:// www.cdc.gov/growthcharts/).
16. Aurora P, Whitehead B, Wade A, et al. Lung transplantation and life extension in children with cystic fibrosis. Lancet 1999;354: 1591-1593.
17. Sharples L, Hathaway T, Dennis C, Caine N, Higenbottam T, Wallwork J. Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation. J Heart Lung Transplant 1993;12: 669-674.
18. Geertsma A, Ten Vergert EM, Bonsel GJ, de Boer WJ, van der Bij W. Does lung transplantation prolong life? A comparison of survival with and without transplantation. J Heart Lung Transplant 1998;17:511-516.
19. Nootens M, Freels S, Kaufmann E, Levy PS, Rich S. Timing of single lung transplantation for primary pulmonary hypertension. J Heart Lung Transplant 1994;13:276-281.
20. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000;161:487-492.
21. Wensel R, Opitz CF, Anker SD, et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002;106:319-324.
22. Lammers AE, Hislop AA, Flynn Y, Haworth SG. The 6-minute walk test: normal values for children of 4-11 years of age. Arch Dis Child 2008;93:464-468.
23. Bridges ND, Clark BJ, Gaynor JW, Spray TL. Outcome of children with pulmonary hypertension referred for lung or heart and lung transplantation. Transplantation 1996;62:1824-1828.
24. Clabby ML, Canter CE, Moller JH, Bridges ND. Hemodynamic data and survival in children with pulmonary hypertension. J Am Coll Cardiol 1997;30:554-560.
25. Taylor CJ, Derrick G, McEwan A, Haworth SG, Sury MR. Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension. Br J Anaesth 2007;98:657-661.
26. Forfia PR, Fisher MR, Mathai SC, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006;174:1034-1041.
27. Saxena N, Rajagopalan N, Edelman K, López-Candales A. Tricuspid annular systolic velocity: a useful measurement in determining right ventricular systolic function regardless of pulmonary artery pressures. Echocardiography 2006;23:750-755.
28. Muthurangu V, Taylor A, Andriantsimiavona R, et al. Novel method of quantifying pulmonary vascular resistance by use of simultaneous invasive pressure monitoring and phase-contrast magnetic resonance flow. Circulation 2004;110:826-834.
29. Marcu CB, Beek AM, Van Rossum AC. Cardiovascular magnetic resonance imaging for the assessment of right heart involvement in cardiac and pulmonary disease. Heart Lung Circ 2006;15:362-370.
30. Kasimir MT, Seebacher G, Jaksch P, et al. Reverse cardiac remodelling in patients with primary pulmonary hypertension after isolated lung transplantation. Eur J Cardiothorac Surg 2004; 26:776-781.
31. Christie JD, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart-lung transplantation report - 2008. J Heart Lung Transplant 2008;27:957-969.